AvoMD is a technology company.
AvoMD has raised $5.0M across 1 funding round.
AvoMD has raised $5.0M in total across 1 funding round.
AvoMD has raised $5.0M in total across 1 funding round.
AvoMD's investors include AlleyCorp, Comcast Ventures, Laconia Capital Group, New Enterprise Associates, Vamos Ventures, Veeral Mehta.
AvoMD is a no-code software platform that digitizes clinical guidelines, pathways, algorithms, and checklists into interactive "virtual clinical consults" accessible at the point of care via standalone web/mobile apps or integrated into electronic health records (EHRs) like Epic, Athena, Cerner, and eClinicalWorks.[1][2][3][4][6][8] It serves provider organizations, health systems, life sciences companies, and medical societies by enabling rapid deployment of customized clinician tools, improving guideline usability, saving clinicians ~50-55% of time, enhancing outcomes, and reducing costs without heavy IT involvement.[2][3][5][6][7][8] Growth momentum includes partnerships with over 10 hospitals like Children’s Minnesota, PM Pediatrics, and Samsung Medical Center, integrations with major EHRs, collaborations with societies like The Wound Healing Society, and proven efficacy in randomized trials and deployments.[4][5][6][8]
AvoMD was founded in 2020 in Brooklyn, New York, by clinicians and technologists addressing clinician burnout from overwhelming medical knowledge, PDFs, paper protocols, and administrative tasks.[1][4][7] Co-founder and Chairman Joongheum Park, MD ("PJ"), an internal medicine physician, clinical informatician, self-taught engineer, and AI expert from New York Presbyterian-Columbia, built the initial software for his own clinical use to save time and inform decisions; he leads AI projects with universities like Columbia and Rutgers.[5][7] CEO and Co-founder Yair Saperstein, MD, MPH, from Harvard, Yale, and Mount Sinai, partnered with PJ to replace static guidelines with interactive tools; they teamed with Laurence Coman, son of physicians passionate about health tech.[4][5][7] The team joined StartUp Health in 2020, achieving early traction with hospital partners and EHR pilots.[4][5][6]
AvoMD rides the digital health trend of AI-enhanced clinical decision support (CDS), addressing clinician information overload amid rising evidence-based care demands in a fragmented healthcare system.[2][3][6][8] Timing aligns with EHR dominance (e.g., Epic's scale) and no-code/low-code proliferation, enabling rapid standardization without IT bottlenecks—critical as burnout drives turnover and value-based care penalizes variability.[6][8] Market forces like AI integration in workflows, partnerships with societies/health systems, and post-pandemic telehealth/EHR reliance favor it; AvoMD influences the ecosystem by empowering non-tech orgs to deploy AI tools, boosting adoption of guidelines from partners like Wound Healing Society, and scaling via shared EHR builds.[2][3][6][8]
AvoMD is poised to expand EHR integrations (e.g., full Cerner rollout), deepen AI features like ambient assistants and predictive consults, and grow partnerships in value-based specialties like nephrology.[6][8] Trends in clinician AI adoption, regulatory pushes for evidence-based care, and no-code healthcare tools will accelerate its trajectory, potentially capturing more of the $11B+ digital health CDS market.[2][6] Its clinician-led model positions it to evolve from guideline digitizer to comprehensive workflow AI platform, further standardizing care and combating burnout across global providers. This builds on its core mission: clinician tools that reclaim time for patients.[7][8]
AvoMD has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $5.0M Seed | AlleyCorp, Comcast Ventures, Laconia Capital Group, New Enterprise Associates, Vamos Ventures, Veeral Mehta |